Tuesday, February 20, 2018 11:18:46 AM
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) has been selected to present its proprietary “WellLinc” EHR interoperability solution at HIMSS 2018.
The Healthcare Information and Management Systems Society (“HIMSS”) is an American not-for-profit organization dedicated to leveraging the potential of digital health to improve both the health status of populations, as well as the quality, cost-effectiveness, access, and value of healthcare. HIMSS North America represents 70,000 individual members, 630 corporate members, and over 450 non-profit organizations.
The HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, executives and vendors from around the world. VitalHub will be one of very few companies to showcase blockchain interoperability solutions at HIMSS 2018, demonstrating strong thought leadership and a commitment to tackling essential problems facing the healthcare sector. This year’s conference will be held March 5-9, 2018 in Las Vegas.
VitalHub has been selected as one of ten vendors to present in the Hyperledger booth 9900-C in the Innovation Live Zone at HIMSS 2018, showcasing products and services being developed using blockchain technologies to improve several high-impact healthcare use-cases. VitalHub’s WellLinc product is an EHR interoperability solution, powered by blockchain technology to enable the secure and interoperable exchange of critical patient health data, across the continuum of care.
"We're thrilled to have VitalHub join us at the Hyperledger booth this year at HIMSS," said Brian Behlendorf, Executive Director, Hyperledger. "It is now more important than ever to showcase production deployments of blockchain-based interoperability healthcare solutions and no better place to do it than at one of the largest and most well respected, health IT conferences. We truly value their support."
“We are excited to connect and engage with digital health industry leaders from around the world, as we showcase VitalHub’s WellLinc interoperability solution,” said Dan Matlow, CEO of VitalHub. “We are committed to improving patient outcomes and healthcare delivery across the continuum of care, creating globally scalable enterprise blockchain solutions.”
ABOUT VITALHUB:
VitalHub uses web, mobile, and Blockchain technology to create disruptive SaaS-based healthcare applications that solve industry-wide problems. VitalHub's aim is to create high-value, secured solutions that enable broad interoperability among existing health data systems. Vitalhub is primarily focused on working with organizations in the Mental Health and Long-Term Care space, to further extend organization's applications across the continuum of care, powered by the security, efficiency, and trust of Blockchain technology.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 200+ clients across North America. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol "VHI".
Recent VHI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:16:59 PM
- VALHI REPORTS FOURTH QUARTER 2023 RESULTS • GlobeNewswire Inc. • 03/07/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:17:01 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 02/29/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:39:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:16:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:15:51 PM
- VALHI REPORTS THIRD QUARTER 2023 RESULTS • GlobeNewswire Inc. • 11/06/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:19:31 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 11/02/2023 08:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:19:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:18:48 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 08/03/2023 08:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 08:15:50 PM
- VALHI REPORTS SECOND QUARTER 2023 RESULTS • GlobeNewswire Inc. • 08/03/2023 08:15:00 PM
- UPDATE--VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 09:09:58 PM
- VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 08:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM